Apoptosis Assays Market By Product (Assay Kits (Caspase Assays, Annexin V and Cell Permeability Assays, DNA Fragmentation Assays, and Mitochondrial Assays), Reagents, Microplates, and Instruments), By Detection Technology (Flow Cytometry, Cell Imaging and Analysis Systems, Spectrophotometry, and Other Detection Technologies), By Application (Drug Discovery and Development, Clinical and Diagnostic End Users, Basic Research, and Stem Cell Research), By End User (Pharmaceutical and Biotechnology Companies, Hospital and Diagnostic Laboratories, and Academic and Research Institutes), and By Region - Trends, Analysis And Forecast Till 2030

Apoptosis Assays Market accounted for USD 4.2 Billion 2020 and is estimated to be USD 9.8 Billion by 2030 and is anticipated to register a CAGR of 8.9%.

Apoptosis assays is a programmed cell death that genetically control ablation of cell during normal development. It eliminates the old cells, unnecessary cells, and unhealthy cells without releasing harmful substances into the surrounding area. The morphological features of apoptotic cells are the compaction of nuclear chromatin, the contraction of cytoplasm and production of membrane-bound apoptotic bodies. The cell imaging and microscopy segment is expected to witness the highest CAGR due to its increasing adoption of cell imaging and microscopy in diagnostic laboratories, drug discovery applications, and basic research. Based on application the target market is classified into drug discovery and development, clinical and diagnostic end users, basic research, and stem cell research. On the basis of end user the market is segmented into pharmaceutical and biotechnology companies, hospital and diagnostic laboratories, and academic and research institutes. 

Increasing adoption of apoptosis assays

The major factor driving the assays market are increasing adoption of apoptosis assays, owing to rising incidence and prevalence of chronic and infectious diseases. In addition, increasing investment for cancer research, growing cell-based research,  is another factor anticipated to fuel growth of the target market over the forecast the period. Moreover, development of apoptosis-modulating drugs and growing cell-based research, are other factors expected to propel growth of the target market over the forecast period. The apoptosis assays market is anticipated to grow with significant rate  due to increase in government support for developing new treatment for chronic disease and presence of high quality infrastructure for clinical and laboratory research. However, dearth of skilled personnel for research and development of apoptosis assays, is a major factor expected to restrain growth of apoptosis assays market over the forecast period. Increasing adoption of apoptosis assays in emerging markets, and increasing rate of chronic disease is a factor expected to create opportunity for growth of the apoptosis assays market over the forecast period. Growing adoption of apoptosis and molecular targeting therapy in the treatment of cancer and technological advancements of apoptosis assays, are the ongoing trends which support growth of the target market over the forecast period.

Apoptosis assays market is segmented based on product, detection technology, application, end user, and region.

Based on product, the apoptosis assays market is segmented into the assay kits, reagents, microplates and instruments. The assays are further classified into caspase assays, annexin V and cell permeability assays, DNA fragmentation assays, and mitochondrial assays. On the basis of product type, the assay kits segment is expected to hold major revenue share in the apoptosis assays market during the forecast period, owing to repeated consumption of assays in various apoptosis procedures. Based on the detection technology, the target market is segmented into flow cytometry, cell imaging and analysis systems, spectrophotometry, and other detection technologies.  Based on detection technology, the cell imaging and microscopy is expected to grow at the fastest growth rate during the forecast period. The cell imaging and microscopy segment is expected to witness the highest CAGR due to its increasing adoption of cell imaging and microscopy in diagnostic laboratories, drug discovery applications, and basic research. Based on application the target market is classified into drug discovery and development, clinical and diagnostic end users, basic research, and stem cell research. On the basis of end user the market is segmented into pharmaceutical and biotechnology companies, hospital and diagnostic laboratories, and academic and research institutes.

Based on the region the apoptosis assays market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America likely to account for significant share in the market for apoptosis assays market. Owing to rising prevalence of chronic disease number of research activities are carried in this region. The Asia Pacific apoptosis assays market is among the emerging markets for apoptosis assays due to the increasing number of research and development facilities in the region, growing investments in the infrastructural sector, and rising number of clinical trial drug studies.                                                      

Apoptosis Assays Market, By Product:

• Assay Kits
  • Caspase Assays
  • Annexin V and Cell Permeability Assays
  • DNA Fragmentation Assays
  • Mitochondrial Assays
• Reagents
• Microplates
• Instruments

Apoptosis Assays Market, By Detection Technology:

• Flow Cytometry
• Cell Imaging and Analysis Systems
• Spectrophotometry
• Other Detection Technologies

Apoptosis Assays Market, By Application:

• Drug Discovery and Development
• Clinical and Diagnostic End Users
• Basic Research
• Stem Cell Research

Apoptosis Assays Market, By End User:

• Pharmaceutical and Biotechnology Companies
• Hospital and Diagnostic Laboratories
• Academic and Research Institutes

Apoptosis Assays Market, By Region:

• North America
  • Middle East & Africa
    • Middle East & Africa Apoptosis Assays Market, By Product
    • Middle East & Africa Apoptosis Assays Market, By Detection Technology
    • Middle East & Africa Apoptosis Assays Market, By Application
    • Middle East & Africa Apoptosis Assays Market, By End User
    • Middle East & Africa Apoptosis Assays Market, By Country
      • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • Latin America Apoptosis Assays Market, By Product
    • Latin America Apoptosis Assays Market, By Detection Technology
    • Latin America Apoptosis Assays Market, By Application
    • Latin America Apoptosis Assays Market, By End User
    • Latin America Apoptosis Assays Market, By Country
      • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • Asia Pacific Apoptosis Assays Market, By Product
    • Asia Pacific Apoptosis Assays Market, By Detection Technology
    • Asia Pacific Apoptosis Assays Market, By Application
    • Asia Pacific Apoptosis Assays Market, By End User
    • Asia Pacific Apoptosis Assays Market, By Country
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • Europe Apoptosis Assays Market, By Product
    • Europe Apoptosis Assays Market, By Detection Technology
    • Europe Apoptosis Assays Market, By Application
    • Europe Apoptosis Assays Market, By End User
    • Europe Apoptosis Assays Market, By Country
      • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • North America Apoptosis Assays Market, By Product
  • North America Apoptosis Assays Market, By Detection Technology
  • North America Apoptosis Assays Market, By Application
  • North America Apoptosis Assays Market, By End User
  • North America Apoptosis Assays Market, By Country
    • U.S.
    • Canada

The key players operating the apoptosis assays market involves Merck KGaA, Thermo Fisher Scientific, Bio-Rad Laboratories, GE Healthcare, Danaher Corporation, Becton, Dickinson and Company, Sartorius AG, Geno Technology, GeneCopoeia, Inc., Bio-Techne Corporation, BioTek Instruments. Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the products to gain a competitive edge in the target market. For instance, in May 2018, GE Healthcare opened a new production facility in Pasching, Austria. The newly built manufacturing site will help to strengthen product supply for biopharmaceutical companies in Europe.

• Merck KgaA
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• GE Healthcare
• Danaher Corporation
• Becton, Dickinson and Company
• Sartorius AG
• Geno Technology
• GeneCopoeia, Inc.
• Bio-Techne Corporation
• BioTek Instruments